Ann Lab Med.  2018 Nov;38(6):613-615. 10.3343/alm.2018.38.6.613.

A Case of Cruoricaptor ignavus Isolated From the Blood of a Patient With Ewing Sarcoma

• Oh J
• Yoo IY
• Song DJ
• Lee JW
• Kim YJ
• Ki CS
• Lee NY
• Huh HJ

• KMID: 2429131
• DOI: http://doi.org/10.3343/alm.2018.38.6.613

Abstract

No abstract available.

MeSH Terms

Humans
Sarcoma, Ewing*

Figure

• 

  Fig. 1 Microscopic image of Cruoricaptor ignavus, showing gram-variable cocci or coccobacilli cells (Gram stain, ×1,000).

• 

  Fig. 2 Colony morphology of Cruoricaptor ignavus on blood agar plate.

Reference

1. Yassin AF, Inglis TJ, Hupfer H, Siering C, Schumann P, Busse HJ, et al. Cruoricaptor ignavus gen. nov., sp. nov., a novel bacterium of the family Flavobacteriaceae isolated from blood culture of a man with bacteraemia. Syst Appl Microbiol. 2012; 35:421–426.

2. CLSI. Interpretive criteria for identification of bacteria and fungi by DNA target sequencing; approved guideline. Wayne, PA: Clinical and Laboratory Standard Institute;2008. CLSI MM18-A.

3. Jamal W, Albert MJ, Rotimi VO. Real-time comparative evaluation of bioMerieux VITEK MS versus Bruker Microflex MS, two matrix-assisted laser desorption-ionization time-of-flight mass spectrometry systems, for identification of clinically significant bacteria. BMC Microbiol. 2014; 14:289.

4. Biswas S, Rolain JM. Use of MALDI-TOF mass spectrometry for identification of bacteria that are difficult to culture. J Microbiol Methods. 2013; 92:14–24.

5. Singhal N, Kumar M, Kanaujia PK, Virdi JS. MALDI-TOF mass spectrometry: an emerging technology for microbial identification and diagnosis. Front Microbiol. 2015; 6:791.